Recent News
Control, Eliminate, Eradicate: What’s the difference? Q&A with Epidemiologist Sanjaya Dhakal
Global health has lots of jargon and terms that can be confusing for people who don’t speak it for a living. Ending preventable diseases is
Heart-to-Heart: Ethiopian Doctor Uses compassion + Medical Training to Fight NTDs
In 30 years of practice, Dr. Zerihun Tadesse has touched nearly every part of the Ethiopian health system. He worked as a general practitioner in
Two-year Study Finds Effective Treatment for Disabling and Stigmatizing Condition
Preliminary results from a two-year study in six countries suggest significant improvement for people affected by lymphedema, thanks particularly to daily hygiene of the affected
Recent News
Control, Eliminate, Eradicate: What’s the difference? Q&A with Epidemiologist Sanjaya Dhakal
Global health has lots of jargon and terms that can be confusing for people who don’t speak it for a
Why We Beat NTDs: Celebrating World NTD Day
January 30 is World NTD Day and World Leprosy Day so this issue of Dispatches reports on neglected tropical diseases
Heart-to-Heart: Ethiopian Doctor Uses compassion + Medical Training to Fight NTDs
In 30 years of practice, Dr. Zerihun Tadesse has touched nearly every part of the Ethiopian health system. He worked
The Task Force family is made up of mission-driven professionals who are dedicated to health equity. If you think you would be a good fit, check out our opportunities.
The Task Force family is made up of mission-driven professionals who are dedicated to health equity. If you think you would be a good fit, check out our opportunities.
BAFANG, CAMEROON
is a 72-year-old river blindness patient in Cameroon’s Bafang district who has benefitted from The Task Force’s Mectizan® Donation Program (MDP) since 2004. She says the treatment has helped save her eyesight and she’s now able to look after her grandchildren. An estimated 205 million people, mostly in Africa, are at risk for river blindness. The disease is categorized as a neglected tropical disease (NTD) because the people it affects are among the most marginalized in society.
Ngo Yeba Anastasie, Participant,
is a 72-year-old river blindness patient in Cameroon’s Bafang district who has benefitted from The Task Force’s Mectizan® Donation Program (MDP) since 2004. She says the treatment has helped save her eyesight and she’s now able to look after her grandchildren. An estimated 205 million people, mostly in Africa, are at risk for river blindness.
